Andrew Worth

Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships

Tatiana I. Netzeva, Andrew Worth, Tom Aldenberg et al. · Alternatives to Laboratory Animals · 2005 · 814 citations

Pharmacy, Pharmacology, Drug Design +9

An evaluation of the implementation of the Cramer classification scheme in the Toxtree software

Grace Patlewicz, Nina Jeliazkova, R.J. Safford et al. · SAR and QSAR in environmental research · 2008 · 504 citations

Pharmacy, Toxicology, Environmental Toxicology +13

CERAPP: Collaborative Estrogen Receptor Activity Prediction Project

Kamel Mansouri, Ahmed Abdelaziz, Aleksandra Rybacka et al. · Environmental Health Perspectives · 2016 · 372 citations · Full text

Pharmacy, Endocrinology, Toxicology +15

Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)

Knut Erik Tollefsen, Stefan Scholz, M Cronin et al. · Regulatory Toxicology and Pharmacology · 2014 · 371 citations · Full text

Pharmacy, Toxicology, Regulatory Science +16

A Modular Approach to the ECVAM Principles on Test Validity

Thomas Härtung, Susanne Bremer, Silvia Casati et al. · Alternatives to Laboratory Animals · 2004 · 339 citations

Education, Bioinformatics, Method Validation +11